Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Human skin releases different steroids, with some coming from sebaceous glands and others from sweat glands.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The method accurately measures sex hormones in human plasma but can have small errors.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Mitotane changes steroid breakdown, affecting cortisol availability.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.